Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Finasteride helps reduce heart issues and improves heart function.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Laser treatment increases hair density and thickness safely in women with hair loss.

Silicon can improve skin and hair health, but more research is needed.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Finasteride shows promise for female hair loss, but more research needed.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.